or Try an Advanced Search...

    Technical Analysis for ADCT - ADC Therapeutics SA

    Grade Last Price % Change Price Change
    B 4.41 -8.70% -0.42
    ADCT closed down 8.7 percent on Wednesday, May 8, 2024, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ADCT trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Down Weakness 0.00%
    Crossed Above 20 DMA Bullish -8.70%
    Crossed Above 50 DMA Bullish -8.70%
    Older End-of-Day Signals for ADCT ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR about 11 hours ago
    Possible Inside Day about 12 hours ago
    Gap Down Partially Closed about 16 hours ago
    Gap Down Closed about 16 hours ago
    60 Minute Opening Range Breakdown about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ADCT Chart by TradingView
    Basic chart:

    Profile

    ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix

    Is ADCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 1 ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024
    Apr 4 ADC Therapeutics gains after data for lymphoma therapy
    Apr 4 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Apr 3 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
    Apr 1 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
    Mar 19 ADC Therapeutics: Real Opportunity With Real Risk In 2024 (Rating Upgrade)
    Mar 16 US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results
    Mar 15 ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
    Mar 14 Q4 2023 ADC Therapeutics SA Earnings Call
    Mar 13 ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript
    See more ADCT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.04
    52 Week Low 0.3599
    Average Volume 565,121
    200-Day Moving Average 2.35
    50-Day Moving Average 4.58
    20-Day Moving Average 4.62
    10-Day Moving Average 4.57
    Average True Range 0.43
    RSI (14) 46.81
    ADX 13.92
    +DI 22.12
    -DI 19.57
    Chandelier Exit (Long, 3 ATRs) 4.02
    Chandelier Exit (Short, 3 ATRs) 5.40
    Upper Bollinger Bands 5.03
    Lower Bollinger Band 4.22
    Percent B (%b) 0.24
    BandWidth 17.66
    MACD Line 0.02
    MACD Signal Line 0.04
    MACD Histogram -0.0177
    Fundamentals Value
    Market Cap 355.63 Million
    Num Shares 80.6 Million
    EPS -2.18
    Price-to-Earnings (P/E) Ratio -2.02
    Price-to-Sales 2.87
    Price-to-Book 2.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.09
    Resistance 3 (R3) 5.16 4.99 4.98
    Resistance 2 (R2) 4.99 4.82 4.96 4.94
    Resistance 1 (R1) 4.70 4.71 4.62 4.64 4.90
    Pivot Point 4.54 4.54 4.50 4.51 4.54
    Support 1 (S1) 4.25 4.36 4.17 4.18 3.92
    Support 2 (S2) 4.08 4.26 4.05 3.88
    Support 3 (S3) 3.79 4.08 3.84
    Support 4 (S4) 3.73